Announced
Financials
Sources
Tags
United States
medical technology
radiopharmaceutical company
Medical Equipment
Acquisition
Minority
Public
Domestic
Pending
Friendly
Single Bidder
Synopsis
Lantheus, a radiopharmaceutical-focused company, agreed to acquire a minority stake in Perspective Therapeutics, a diversified medical technology and radiopharmaceutical company, for $33m. “This collaboration with Lantheus, a leader in the radiopharmaceutical space, marks a significant milestone in advancing treatment options for various cancers, bringing us closer to more effective and targeted interventions,” Thijs Spoor, Perspective Therapeutics CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.